According to a new market research report the Bioburden Testing Market is expected to reach around $565.6 Million by 2019 with a CAGR of 9.8% from 2014 to 2019.

Browse 96 market data Tables and 46 Figures spread through 180 Pages and in-depth TOC on "Bioburden Testing Market”

http://www.marketsandmarkets.com/Market-Reports/bioburden-testing-market-17983056.html

Early buyers will receive 10% customization on reports.

The report segments the bioburden testing market on the basis of products and services, test types, applications, end users, and regions. In the product segment, consumables accounted for the largest share in 2014; however, the culture media and reagents & kits segment will grow at the highest CAGR during the forecast period as culture media and reagents & kits are most commonly used for bioburden testing. Factors such as the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination are driving the growth of the bioburden testing market.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=17983056

On the basis of products, the microbial limit testing market is segmented into consumables and instruments. The consumables market is further segmented into culture media and reagents & kits and other consumables. The instruments market is further segmented into PCR, microscopes, automated microbial identification systems, and other instruments. On the basis of test types, the global bioburden market is segmented into aerobic count, anaerobic count, fungi/mold count, and spores count. On the basis of applications, the market is segmented into raw material testing, medical devices testing, in-process testing, sterilization validation testing, and equipment cleaning validation. Based on end users, the market is segmented into pharmaceutical and biotechnology companies, medical devices manufacturers, contract manufacturing organizations (CMOs), manufacturers of food & beverage and agricultural products, and microbial testing laboratories.

Get Report Sample @ http://www.marketsandmarkets.com/requestsample.asp?id=17983056

Based on regions, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is estimated to account for the largest share of the market in 2014, while Asia-Pacific is likely to witness the highest growth in the forecast period.

Key players in the Bioburden Testing Market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co. Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).Get Report

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: [email protected]